• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.26% Nasdaq Up0.23%

    Sagent Pharmaceuticals, Inc. (SGNT)

    -NasdaqGS
    23.57 Up 0.15(0.64%) May 4, 4:00PM EDT
    |After Hours : 23.57 0.00 (0.00%) May 4, 4:36PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 83,561   65,359   69,194   70,869  
    Cost of Revenue59,145  46,589  46,602  50,485  
    Gross Profit 24,416   18,770   22,592   20,384  
    Operating Expenses
    Research Development9,075  3,677  10,037  4,020  
    Selling General and Administrative11,605  10,914  10,695  10,013  
    Non Recurring197  872   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 5,050   4,044   3,318   6,632  
    Income from Continuing Operations
    Total Other Income/Expenses Net(213)(536)157  (86)
    Earnings Before Interest And Taxes4,837  3,508  3,475  6,546  
    Interest Expense1,547  195  233  213  
    Income Before Tax3,290  3,313  3,242  6,333  
    Income Tax Expense(26,477)1,387  173  1,214  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops31,278  2,663  4,527  5,400  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 29,767   1,926   3,069   5,119  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 29,767   1,926   3,069   5,119  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.